A detailed history of Alyeska Investment Group, L.P. transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Alyeska Investment Group, L.P. holds 1,000,000 shares of ROIV stock, worth $12.7 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
1,000,000
Previous 1,000,000 -0.0%
Holding current value
$12.7 Million
Previous $10.6 Million 9.18%
% of portfolio
0.06%
Previous 0.06%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$10.36 - $11.74 $10.4 Million - $11.7 Million
1,000,000 New
1,000,000 $10.6 Million
Q1 2023

May 15, 2023

BUY
$6.92 - $9.98 $2.72 Million - $3.92 Million
392,812 Added 232.71%
561,612 $4.14 Million
Q4 2022

Feb 14, 2023

BUY
$3.36 - $7.99 $567,168 - $1.35 Million
168,800 New
168,800 $1.35 Million

Others Institutions Holding ROIV

About Roivant Sciences Ltd.


  • Ticker ROIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 704,382,976
  • Market Cap $8.95B
  • Description
  • Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...
More about ROIV
Track This Portfolio

Track Alyeska Investment Group, L.P. Portfolio

Follow Alyeska Investment Group, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alyeska Investment Group, L.P. with notifications on news.